Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastrointest Endosc. Oct 16, 2014; 6(10): 493-498
Published online Oct 16, 2014. doi: 10.4253/wjge.v6.i10.493
Published online Oct 16, 2014. doi: 10.4253/wjge.v6.i10.493
n = 3015 | |
Age, mean ± SD, yr | 59.6 ± 10.4 |
Male | 1771 (70.0) |
Comorbidity | |
Hypertension | 564 (18.7) |
Cardiovascular or cerebrovascular disease | 389 (12.9) |
Chronic renal failure | 23 (0.8) |
Liver cirrhosis | 75 (2.5) |
Diabetes mellitus | 157 (5.2) |
Cancer history | 353 (11.7) |
Anti-coagulants and anti-platelets | |
Aspirin | 253 (8.3) |
Clopidogrel | 57 (1.9) |
Warfarin | 43 (1.4) |
Size of lesion, mean ± SD, mm | 11.1 ± 6.8 |
Locations | |
Right side colon | 1296 (43.0) |
Cecum | 109 (3.6) |
Ascending colon | 805 (26.7) |
Transverse colon | 382 (12.7) |
Left side colon | 1719 (57.0) |
Descending colon | 346 (11.5) |
Sigmoid colon | 817 (25.9) |
Rectum | 556 (18.4) |
Morphologic classification | |
Pedunculated type | 550 (18.2) |
Piecemeal resection | 130 (4.3) |
Pathologic complete resection | 2956 (98.0) |
Horizontal margin involvement | 31 (1.0) |
Vertical margin involvement | 10 (0.3) |
Serious immediate bleeding1 | 78 (2.6) |
Prophylactic hemostatic clipping | 345 (11.4) |
Delayed bleeding | 25 (0.8) |
Spurting, n | 2 |
Oozing, n | 13 |
Clots with or without vessel exposure, n | 10 |
Onset of delayed post-EMR bleeding, mean ± SD (range), h | 9.9 ± 0.4 |
(7-72) | |
Perforation | 6 (0.2) |
Histology | |
Adenoma | 2357 (78.2) |
Tubular adenoma | 2026 (67.2) |
Tubulovillous adenoma | 233 (7.7) |
Villous adenoma | 99 (3.3) |
Serrated adenoma | 66 (2.2) |
Carcinoma | 89 (3.0) |
Submucosal invasive carcinoma | 10 (0.3) |
Hyperplastic polyp | 413 (13.6) |
Others | 90 (3.0) |
Delayed bleeding n = 25 | Uneventful group n = 2990 | P value | |
Age, mean ± SD, yr | 58.4 ± 10.1 | 59.6 ± 10.4 | 0.646 |
Male | 15 (60.0) | 1756 (58.7) | 0.898 |
Laboratory before EMR | |||
Hemoglobin, g/dL | 13.2 ± 1.4 | 13.66 ± 1.8 | 0.187 |
Platelet, × 103 count/mm3 | 60.5 ± 12.1 | 71.9 ± 1.3 | 0.81 |
Prothrombin time, INR | 0.984 ± 0.067 | 0.989 ± 0.528 | 0.785 |
Activated partial thromboplastin time, s | 33.8 ± 4.4 | 34.9 ± 23.2 | 0.665 |
Comorbidity | |||
Hypertension | 5 (20.0) | 559 (18.7) | 0.800 |
Cardiovascular or cerebrovascular disease | 5 (20.0) | 384 (12.8) | 0.362 |
Chronic renal failure | 2 (8.0) | 21 (0.7) | 0.015 |
Liver cirrhosis | 1 (4.0) | 74 (2.5) | 0.131 |
Diabetes mellitus | 3 (12.0) | 154 (5.1) | 0.140 |
Cancer history | 3 (12.0) | 350 (11.7) | 1.000 |
Anti-coagulants and anti-platelets | |||
Aspirin | 3 (12.0) | 250 (8.4) | 1.000 |
Clopidogrel | 1 (4.0) | 56 (1.9) | 0.381 |
Warfarin | 0 (0.0) | 43 (1.4) | 1.000 |
Size of lesion, mean ± SD, mm | 25.8 ± 11.6 | 11.0 ± 6.6 | < 0.001 |
Locations | |||
Right side colon1 | 8 (32.0) | 1288 (43.1) | 0.314 |
Morphologic classification | |||
Pedunculated | 11 (44.0) | 539 (18.0) | 0.003 |
Piecemeal resection | 6 (24.0) | 124 (4.1) | 0.001 |
Pathologic complete resection | 25 (100.0) | 2954 (79.9) | 1.000 |
Horizontal margin involvement | 0 (0.0) | 31 (1.0) | 1.000 |
Vertical margin involvement | 0 (0.0) | 10 (0.3) | 1.000 |
Serious immediate bleeding2 | 3 (12.0) | 75 (2.5) | 0.025 |
Prophylactic hemostatic clipping | 4 (16.0) | 341 (11.4) | 0.319 |
Histology | |||
Adenoma | 23 (92.0) | 2337 (78.2) | 0.140 |
Carcinoma | 1 (4.0 ) | 88 (18.4) | 0.529 |
Hyperplastic polyp | 1 (4.0) | 412 (13.8) | 0.240 |
Others | 0 (0.0) | 90 (3.0) | 1.000 |
- Citation: Kim HH, Kim SE, Cho EJ. What can be the criteria of outpatient-based endoscopic resection for colon polyp? World J Gastrointest Endosc 2014; 6(10): 493-498
- URL: https://www.wjgnet.com/1948-5190/full/v6/i10/493.htm
- DOI: https://dx.doi.org/10.4253/wjge.v6.i10.493